Page 901 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 901

632     PART 5: Infectious Disorders

                     ■  MANAGEMENT                                     with methemoglobinemia, thrombocytopenia, neutropenia, liver dys-

                 Trimethoprim-sulfamethoxazole (TMP-SMX) is effective against  P   function, rash, and gastrointestinal upset, which often interferes with
                 jirovecii, as well as various gram-negative and gram-positive bacte-  oral drug administration. Dapsone-induced methemoglobinemia and
                 rial organisms. Intravenous trimethoprim-sulfamethoxazole (15 mg/kg    hemolytic anemia are particularly severe among individuals with glucose-
                                                                       6-phosphate dehydrogenase deficiency, so prescreening for this glucose-
                 of the trimethoprim component divided three times daily) is recom-
                                                   <70 mm Hg,  A-a  gradient     6-phosphate dehydrogenase deficiency should be considered. It is also
                 mended for severely ill patients (eg, Pa O 2          important to note that the hemolytic anemia will produce an increase in
                 >45 mm Hg).  The optimal duration of therapy is 21 days (see                                         85
                           82
                 Table  69-4). Side effects of trimethoprim-sulfamethoxazole include   LDH that should not be misinterpreted as a sign of  worsening PJP.
                                                                         If used for therapy, pentamidine is usually administered intravenously
                 rash (including severe mucocutaneous reactions), cytopenias, and renal
                 dysfunction. A number of reports have documented successful desensi-  (4 mg/kg once daily diluted in 250 mL of 5% dextrose and water) for 14
                                                                       to 21 days. Adverse reactions to pentamidine are common, occurring in
                                https://kat.cr/user/tahir99/
                 tization of TMP-SMX-allergic patients using progressively larger doses
                 of the drug. Hypersensitivity-type reactions such as fever or rash can   up to 100% of patients in some series. Common adverse drug reactions
                                                                       include renal and hepatic dysfunction, neutropenia, thrombocytopenia,
                 also be treated with diphenhydramine or corticosteroids. 83
                   Dapsone (100 mg by mouth daily), a sulfone, is effective against   hyponatremia,  rash, fever, and gastrointestinal  upset. Hypotension
                 Pneumocystis in combination with trimethoprim (TMP) (15 mg/kg daily,   is common with pentamidine infusion. Administering pentamidine
                 in three doses per day). This combination has similar efficacy and better   slowly over several hours can minimize hypotension. If severe or long-
                                                                       lasting hypotension occurs, this should be treated supportively with a
                 tolerability and safety compared to TMP-SMX.  Nonetheless, adverse
                                                    84
                 reactions of this combination are common, including hemolytic anemia   vasopressor because it is readily reversible. Occasionally, carbohydrate
                   TABLE 69-4    Antimicrobial Therapy of Common Infections in AIDS Patients
                  Infection    Drug of Choice         Total Daily Dose   Dose Interval  Route  Usual Duration  Alternative Therapy
                  Protozoa
                  Toxoplasmosis   Pyrimethamine a     200 mg loading dose, then   Daily  PO  ≥6 weeks b  Pyrimethamine (leucovorin) plus
                  (Toxoplasma gondii)                 50 mg (if <60 kg), or 75 mg (if                clindamycin 600 mg IV  or PO q6h,
                                                                                                                 c
                                                      >60 kg)
                                                                                                     Or
                                                                                                     TMP-SMX (TMP 5 mg/kg and SMX
                                                                                                     25 mg/kg) IV or PO BID
                               plus
                               Sulfadiazine           4000 mg (if <60 kg), or 6000 mg   6 h  PO  >6 weeks
                                                      (if >60 kg)
                               plus                   10-25 mg
                               Leucovorin                                Daily      PO    >6 weeks
                               Maintenance therapy:
                               Pyrimethamine a        25-50 mg           Daily      PO    Indefinitely  Pyrimethamine  25-50 mg/d PO
                                                                                                             a
                               plus                                                                  plus leucovorin 10-25 mg PO daily
                                                                                                     plus clindamycin 600 mg PO q8h
                                                                                                     Or
                                                                                                     TMP-SMX DS 1 tablet BID
                               Sulfadiazine           2000-4000 mg       12 h       PO    Indefinitely
                               plus
                               Leucovorin             10-25 mg           Daily      PO    Indefinitely
                  Cryptosporidiosis   No proven effective therapy                                    Nitazoxanide 500-1000 mg PO BID for
                  (Cryptosporidium)                                                                  14 d, or Paromomycin 500 mg PO QID
                                                                                                     for 14-21 d (optimize antiretroviral
                                                                                                     therapy, rehydrate)
                               Rehydration and electrolyte replacement
                               Optimize antiretroviral therapy
                  Isosporiasis (Isospora  Trimethoprim-sulfamethoxazole  640 mg
                  belli)                              3200 mg            6 h        PO, IV  10 d d   Pyrimethamine 50-75 mg PO daily plus
                                                                                                     leucovorin 5-10 mg PO daily for 4 weeks;
                                                                                                     or ciprofloxacin 500 mg PO BID × 7 d
                               Maintenance therapy:
                               Trimethoprim, 160 mg,                     3 times per week PO  Until CD4 >200  Pyrimethamine 25 mg PO daily plus
                               sulfamethoxazole, 800 mg                                   for >6 months  folinic acid 5 mg PO daily
                                                                                                                   (Continued)









            section05_c61-73.indd   632                                                                                1/23/2015   12:48:20 PM
   896   897   898   899   900   901   902   903   904   905   906